DNAGENEA™ - the innovative service of biogenea pharmaceuticals™ provides the opportunity of isolation, genetic analysis and long term preservation of genetic material from various sources (blood, amniotic fluid, horionic lachnes etc.) In this way the possibility of a hereditary genetic diseases or mutations that can be transferred from parents to children through DNA can be estimated.

DNAGENEA™ provides the services below:

Molecular tests for the identification of mutated genes

DNA sequencing

Determination of number of copies of genes

Molecular control of mitochondrials

Molecular control for leukemia and lymphomas

Molecular control for cancer

Control of risk factors

Control of single-parent disomy

Personalised pharmacotherapy (pharmacotyping)

Adjusted diagnostic tests